BioMarin Pharmaceutical Inc. (0HNC.L)
USD 66.73
(-0.75%)
USD 66.73
(-0.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 159.25 Million | 175.9 Million | 304.53 Million | 85.36 Million | 48.26 Million | 20.2 Million |
| Net Income | 167.64 Million | 141.56 Million | -64.08 Million | 859.1 Million | -23.84 Million | -77.21 Million |
| Depreciation & Amortization | 104.38 Million | 101.96 Million | 108.03 Million | 105.17 Million | 105.3 Million | 95.67 Million |
| Deferred income taxes | -44.98 Million | -52.08 Million | -15.6 Million | -888.9 Million | -82.76 Million | -68.37 Million |
| Stock-based compensation | 207.09 Million | 196.3 Million | 197.26 Million | 189.71 Million | 159.86 Million | 148.81 Million |
| Change in working capital | -336.53 Million | -96.38 Million | 66.03 Million | -224.41 Million | -101.09 Million | -49.42 Million |
| Other non-cash items | 756.16 Million | -115.46 Million | 12.88 Million | 44.7 Million | -9.2 Million | -29.27 Million |
| Investing Cash Flow | -111.24 Million | -20.02 Million | -366.31 Million | -53.62 Million | -31.02 Million | 264.35 Million |
| Investments in PPE | -107.61 Million | -131.54 Million | -119.22 Million | -137.51 Million | -163.4 Million | -144.62 Million |
| Acquisitions | 10.92 Billion | - | -23.64 Million | -23.2 Million | 6.62 Million | 50 Million |
| Investment purchases | -868.49 Million | -611.8 Million | -937.14 Million | -538.37 Million | -632.02 Million | -634.75 Million |
| Sales/Maturities of investments | 864.86 Million | 619.99 Million | 691.04 Million | 555.83 Million | 740.21 Million | 993.73 Million |
| Other Investing Activities | -10.92 Billion | 103.32 Million | 22.65 Million | 89.64 Million | 17.57 Million | -10 Thousand |
| Financing Cash Flow | -18.72 Million | -18.65 Million | -48 Thousand | 181.11 Million | -74.67 Million | -388 Million |
| Debt repayment | -2.28 Million | -2.6 Million | -3.03 Million | -381.9 Million | -5.08 Million | -374.95 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -76.31 Million | -54.28 Million | -45.8 Million | -50 Million | -42.68 Million | -35.91 Million |
| Common Stock Issuance | 69.35 Million | 69.33 Million | 49.19 Million | 71.91 Million | 31.61 Million | 67.48 Million |
| Other Financing Activities | -85.79 Million | -16.04 Million | 2.99 Million | 613.02 Million | -47.44 Million | -13.05 Million |
| Accounts receivables | -190.43 Million | -82.03 Million | 65.57 Million | -59.03 Million | -37.85 Million | -54.27 Million |
| Accounts payables | 68.85 Million | 59.01 Million | 15.68 Billion | -68.71 Million | 50.08 Million | 20.62 Million |
| Inventory | -157.05 Million | -68.26 Million | -35.06 Million | -61.15 Million | -107.55 Million | -23.74 Million |
| Other working capital | -57.89 Million | -5.1 Million | -15.65 Billion | -35.51 Million | -5.76 Million | 7.97 Million |
| Cash at beginning of period | 724.53 Million | 587.27 Million | 649.15 Million | 437.44 Million | 493.98 Million | 598.02 Million |
| Cash at end of period | 755.12 Million | 724.53 Million | 587.27 Million | 649.15 Million | 437.44 Million | 493.98 Million |
| Capital Expenditure | -107.61 Million | -131.54 Million | -119.22 Million | -137.51 Million | -163.4 Million | -144.62 Million |
| Effect of forex changes on cash | 1.3 Billion | 32 Thousand | -57 Thousand | -1.15 Million | 902 Thousand | -598 Thousand |
| Net cash flow / Change in cash | 30.59 Million | 137.25 Million | -61.88 Million | 211.71 Million | -56.53 Million | -104.04 Million |
| Free Cash Flow | 51.64 Million | 44.36 Million | 185.31 Million | -52.15 Million | -115.14 Million | -124.41 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 301.72 Billion | 107.17 Million | 88.66 Million | 167.64 Million | 20.37 Million | 40.37 Million |
| Depreciation & Amortization | 72.76 Billion | 26.46 Million | 27.35 Million | 104.38 Million | 26.86 Million | 25.68 Million |
| Deferred income taxes | 13.7 Billion | 1.25 Million | 285 Thousand | -44.98 Million | -24.84 Million | -15.02 Million |
| Stock-based compensation | 149.54 Billion | 47.91 Million | 58.24 Million | 207.09 Million | 54.85 Million | 48.38 Million |
| Change in working capital | 172.3 Million | -66.92 Million | -105.38 Million | -336.53 Million | -97.11 Million | 39.91 Million |
| Other non-cash items | -150.86 Billion | 182.25 Million | 169.97 Million | 756.16 Million | 261.01 Million | 42.21 Million |
| Investing Cash Flow | 60.01 Billion | 90.48 Million | -14.23 Million | -111.24 Million | -64.96 Million | -45.79 Million |
| Investments in PPE | -65.83 Billion | -21.83 Million | -34.1 Million | -107.61 Million | -36.69 Million | -23.41 Million |
| Acquisitions | - | - | - | 10.92 Billion | - | 24.06 Million |
| Investment purchases | -352.17 Billion | -73.79 Million | -121.66 Million | -868.49 Million | -141.45 Million | -282.99 Million |
| Sales/Maturities of investments | 478.11 Billion | 186.11 Million | 131.53 Million | 864.86 Million | 113.18 Million | 260.61 Million |
| Other Investing Activities | -94 Million | 111.8 Million | 10 Million | -10.92 Billion | 1.00 | -24.06 Million |
| Financing Cash Flow | -529.27 Billion | 12.61 Million | -42.79 Million | -18.72 Million | 10.84 Million | -788 Thousand |
| Debt repayment | -60 Thousand | -18 Thousand | -42 Thousand | -2.28 Million | -45 Thousand | -606 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 66.73 Million | -16.79 Million | -49.94 Million | -76.31 Million | -3.92 Million | -4.53 Million |
| Common Stock Issuance | -36.61 Million | 29.42 Million | 7.19 Million | 69.35 Million | 14.8 Million | 4.35 Million |
| Other Financing Activities | -529.3 Billion | -16.79 Million | -49.94 Million | -85.79 Million | -3.92 Million | 4.53 Million |
| Accounts receivables | -130.39 Billion | -52.69 Million | -3.38 Million | -190.43 Million | -58.49 Million | 13.89 Million |
| Accounts payables | 68.07 Billion | 4.74 Million | -59 Million | 68.85 Million | 12.52 Million | 81.42 Million |
| Inventory | -29.21 Billion | -30.58 Million | -16.82 Million | -157.05 Million | -59.11 Million | -41.47 Million |
| Other working capital | 14.55 Million | 11.61 Million | -26.17 Million | -57.89 Million | 7.96 Million | -13.92 Million |
| Cash at beginning of period | 972.15 Million | 746.99 Million | 755.12 Million | 724.53 Million | 785.41 Million | 694.38 Million |
| Cash at end of period | 675.44 Billion | 972.15 Million | 746.99 Million | 755.12 Million | 755.12 Million | 785.41 Million |
| Capital Expenditure | -65.83 Billion | -21.83 Million | -34.1 Million | -107.61 Million | -36.69 Million | -23.41 Million |
| Effect of forex changes on cash | 395.7 Million | 3.3 Million | 1.92 Billion | 1.3 Billion | 47.03 Million | 1.97 Million |
| Net cash flow / Change in cash | 674.47 Billion | 225.15 Million | -8.13 Million | 30.59 Million | -30.28 Million | 91.03 Million |
| Free Cash Flow | 321.21 Billion | 96.92 Million | 12.86 Million | 51.64 Million | -9.21 Million | 112.22 Million |
FMCCL
7202
CDMO
AEG
TPHQ
BLMH